FUNDACIO HOSPITAL UNI VALL D HEBRON INST DE RECERCA has a total of 14 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PACYLEX PHARMACEUTICALS INC, UNIV YALE INC and PESTELL RICHARD G.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 1 | |
#5 | Spain | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Montaner Villalonga Joan | 4 |
#2 | Julia Cano Antoni | 3 |
#3 | Simo Canonge Rafael | 3 |
#4 | Hernandez Pascual Cristina | 3 |
#5 | Tornero Molina Jesus | 3 |
#6 | Marsal Barril Sara | 3 |
#7 | Rosell Novel Anna | 2 |
#8 | Roig Serra Anna | 2 |
#9 | Alonso Martin Joaquin Jesus | 1 |
#10 | Garcia-Berrocoso Teresa | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016016824A1 | Differential diagnosis and therapy selection for rheumatoid arthritis and psoriatic arthritis | |
CN105007931A | Peptides for use in the topical treatment of retinal neurodegenerative disesases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role | |
WO2014041064A1 | New biomarkers for the diagnosis and/or prognosis of clear cell renal cell carcinoma | |
ES2524164A1 | PROGNOSIS OF RESPONSE TO ANTI-TNFALFA TREATMENT IN PATIENTS OF Rheumatoid ARTHRITIS | |
EP2725360A1 | Biomarkers for the prognosis of ischemic stroke | |
EP2660251A1 | Antibodies or fragments thereof against hemopexin for use in the treatment of ocular diseases | |
WO2012136443A1 | Endothelial progenitor cells labelled with superparamagnetic iron oxide micro and nanoparticles in cerebrovascular disorders, process for their preparation and uses thereof |